BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8747756)

  • 21. Attenuation of morphine tolerance and dependence by aminoguanidine in mice.
    Abdel-Zaher AO; Hamdy MM; Aly SA; Abdel-Hady RH; Abdel-Rahman S
    Eur J Pharmacol; 2006 Jul; 540(1-3):60-6. PubMed ID: 16730698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atorvastatin attenuates the antinociceptive tolerance of morphine via nitric oxide dependent pathway in male mice.
    Hassanipour M; Amini-Khoei H; Shafaroodi H; Shirzadian A; Rahimi N; Imran-Khan M; Rezayat SM; Dehpour A
    Brain Res Bull; 2016 Jul; 125():173-80. PubMed ID: 27381980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrease in arterial pressure induced by adrenomedullin in the hypothalamic paraventricular nucleus is mediated by nitric oxide and GABA.
    Xu Y; Krukoff TL
    Regul Pept; 2004 Jun; 119(1-2):21-30. PubMed ID: 15093693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide regulation of lingual blood flow in the rat.
    Roberts ZV; Koss MC
    Nitric Oxide; 2001 Jun; 5(3):271-7. PubMed ID: 11384200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between brain nitric oxide synthase activity and opiate withdrawal.
    Leza JC; Lizasoain I; Cuéllar B; Moro MA; Lorenzo P
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):349-54. PubMed ID: 8692292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of nitric oxide in catalepsy and hyperthermia in morphine-dependent rats.
    Afify EA; Daabees TT; Gabra BH; Abou Zeit-Har MS
    Pharmacol Res; 2001 Dec; 44(6):533-9. PubMed ID: 11735362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoxetine suppresses morphine tolerance and dependence: modulation of NO-cGMP/DA/serotoninergic pathways.
    Singh VP; Jain NK; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 2003 May; 25(4):273-80. PubMed ID: 12808472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ng-nitro-L-arginine, an NOS inhibitor, reduces tolerance to morphine in the rat locus coeruleus.
    Highfield DA; Grant S
    Synapse; 1998 Jul; 29(3):233-9. PubMed ID: 9635893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice.
    Raghavendra V; Kulkarni SK
    Eur J Pharmacol; 2000 Dec; 409(3):279-89. PubMed ID: 11108822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of nitric oxide synthase inhibitors on the sedative effect of clonidine.
    Soares de Moura R; Rios AA; de Oliveira LF; Resende AC; de Lemos Neto M; Santos EJ; Correia ML; Tano T
    Anesth Analg; 2001 Nov; 93(5):1217-21. PubMed ID: 11682401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice.
    Dambisya YM; Lee TL
    Br J Pharmacol; 1996 Mar; 117(5):914-8. PubMed ID: 8851510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide and opioid tolerance.
    Babey AM; Kolesnikov Y; Cheng J; Inturrisi CE; Trifilletti RR; Pasternak GW
    Neuropharmacology; 1994 Nov; 33(11):1463-70. PubMed ID: 7532830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of nitric oxide synthase inhibitor, 7-nitroindazole, on discriminative stimulus and somatic effects of naloxone in morphine-dependent rats.
    Medvedev IO; Dravolina OA; Bespalov AY
    Eur J Pharmacol; 1999 Jul; 377(2-3):183-6. PubMed ID: 10456428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence.
    Naidu PS; Singh A; Joshi D; Kulkarni SK
    Addict Biol; 2003 Sep; 8(3):327-36. PubMed ID: 13129835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of nitric oxide inhibition with L-NAME on the blood pressure and renal response to clonidine in conscious rats.
    Smyth DD; Penner SB
    Proc West Pharmacol Soc; 2002; 45():18-9. PubMed ID: 12434514
    [No Abstract]   [Full Text] [Related]  

  • 36. 7-nitroindazole, nitric oxide synthase inhibitor, attenuates physical dependence on butorphanol in rat.
    Tian YH; Lee KW; You IJ; Lee SY; Jang CG
    Synapse; 2008 Aug; 62(8):582-9. PubMed ID: 18512210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impairment of osteoblast growth by nitric oxide synthase inhibitors: an effect independent of nitric oxide and arginine transport inhibition.
    Riancho JA; Zarrabeitia MT; Salas E; González-Macías J
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):663-7. PubMed ID: 9121222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of normotensive and hypertensive nitric oxide synthase inhibitors on morphine withdrawal syndrome in rats.
    Cappendijk SL; Duval SY; de Vries R; Dzoljic MR
    Neurosci Lett; 1995 Jan; 183(1-2):67-70. PubMed ID: 7538210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NO synthase inhibitors attenuate locus coeruleus catecholamine metabolism and behavior induced by morphine withdrawal.
    Javelle N; Bérod A; Renaud B; Lambás-Señas L
    Neuroreport; 2002 Apr; 13(5):725-8. PubMed ID: 11973478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
    Machelska H; Labuz D; Przewłocki R; Przewłocka B
    J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.